Hydroxyurea therapy decreases coagulation and endothelial activation in sickle cell disease: a Longitudinal Study

Authors

Laila Elsherif, University of Tennessee Health Science Center
Lara C. Scott, University of Tennessee Health Science Center
David Wichlan, The University of North Carolina at Chapel Hill
Susan K. Jones, The University of North Carolina at Chapel Hill
Joacy G. Mathias, The University of North Carolina at Chapel Hill
Jessica H. Shen, The University of North Carolina at Chapel Hill
Matthew P. Smeltzer, University of Memphis
Kenneth I. Ataga, University of Tennessee Health Science Center

Publication Title

British Journal of Haematology

Recommended Citation

Elsherif, L., Scott, L., Wichlan, D., Jones, S., Mathias, J., Shen, J., Smeltzer, M., & Ataga, K. (2021). Hydroxyurea therapy decreases coagulation and endothelial activation in sickle cell disease: a Longitudinal Study. British Journal of Haematology, 194 (3), e71-e73. https://doi.org/10.1111/bjh.17650